» Articles » PMID: 27553470

Gallium-68 EDTA PET/CT for Renal Imaging

Overview
Journal Semin Nucl Med
Specialty Nuclear Medicine
Date 2016 Aug 25
PMID 27553470
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear medicine renal imaging provides important functional data to assist in the diagnosis and management of patients with a variety of renal disorders. Physiologically stable metal chelates like ethylenediaminetetraacetic acid (EDTA) and diethylenetriamine penta-acetate (DTPA) are excreted by glomerular filtration and have been radiolabelled with a variety of isotopes for imaging glomerular filtration and quantitative assessment of glomerular filtration rate. Gallium-68 ((68)Ga) EDTA PET usage predates Technetium-99m ((99m)Tc) renal imaging, but virtually disappeared with the widespread adoption of gamma camera technology that was not optimal for imaging positron decay. There is now a reemergence of interest in (68)Ga owing to the greater availability of PET technology and use of (68)Ga to label other radiotracers. (68)Ga EDTA can be used a substitute for (99m)Tc DTPA for wide variety of clinical indications. A key advantage of PET for renal imaging over conventional scintigraphy is 3-dimensional dynamic imaging, which is particularly helpful in patients with complex anatomy in whom planar imaging may be nondiagnostic or difficult to interpret owing to overlying structures containing radioactive urine that cannot be differentiated. Other advantages include accurate and absolute (rather than relative) camera-based quantification, superior spatial and temporal resolution and integrated multislice CT providing anatomical correlation. Furthermore, the (68)Ga generator enables on-demand production at low cost, with no additional patient radiation exposure compared with conventional scintigraphy. Over the past decade, we have employed (68)Ga EDTA PET/CT primarily to answer difficult clinical questions in patients in whom other modalities have failed, particularly when it was envisaged that dynamic 3D imaging would be of assistance. We have also used it as a substitute for (99m)Tc DTPA if unavailable owing to supply issues, and have additionally examined the role of (68)Ga EDTA PET/CT for measuring glomerular filtration rate and split renal function.

Citing Articles

A Simple Kit for the Good-Manufacturing-Practice Production of [Ga]Ga-EDTA.

Skulska M, Falborg L Molecules. 2023; 28(16).

PMID: 37630382 PMC: 10459059. DOI: 10.3390/molecules28166131.


Quantitative assessment of renal functions using Ga-EDTA dynamic PET imaging in renal injury in mice of different origins.

Ding Y, Liu Y, Zhang L, Deng Y, Chen H, Lan X Front Med (Lausanne). 2023; 10:1143473.

PMID: 37051215 PMC: 10083276. DOI: 10.3389/fmed.2023.1143473.


So, you want to get into "total-body" PET/CT scanning? An installation guide for beginners!.

Hicks R Cancer Imaging. 2023; 23(1):35.

PMID: 37020313 PMC: 10077644. DOI: 10.1186/s40644-023-00542-1.


A Clinical Guide to Peptide Receptor Radionuclide Therapy with Lu-DOTATATE in Neuroendocrine Tumor Patients.

Becx M, Minczeles N, Brabander T, de Herder W, Nonnekens J, Hofland J Cancers (Basel). 2022; 14(23).

PMID: 36497273 PMC: 9737149. DOI: 10.3390/cancers14235792.


First experiences with dynamic renal [Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.

Kersting D, Sraieb M, Seifert R, Fragoso Costa P, Kazek S, Kessler L Eur J Nucl Med Mol Imaging. 2022; 49(10):3373-3386.

PMID: 35412053 PMC: 9002049. DOI: 10.1007/s00259-022-05781-1.